Market Overview

Renal Anemia Therapeutics: Global Market Overview & Outlook 2018-2022 - Key Players Featured include AMAG Pharmaceuticals, AstraZeneca, Daiichi Sankyo, GlaxoSmithKline, and Pharmacosmos -


The "Global
Renal Anemia Therapeutics Market 2018-2022"
report has been
added to's offering.

The global renal anemia therapeutics market to grow at a CAGR of 8.33%
during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the market landscape and
its growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market.

One trend in the market is growing focus of vendors on emerging
economies. Emerging economies such as China, India, and Brazil are
witnessing a growing prevalence of CKD, which is encouraging renal
anemia therapeutics vendors to invest in these markets.

According to the report, one driver in the market is presence of large
pool of CKD patients. The growing prevalence of CKD increases the risk
of renal disease-induced ailments such as anemia, which will contribute
to the demand for renal anemia therapeutics. Patients affected by health
conditions such as diabetes, high blood pressure, and glomerulonephritis
are susceptible to developing chronic renal ailments.

Further, the report states that one challenge in the market is
side-effects of oral administration. The limitations associated with
conventional oral therapies to treat anemia will reduce the demand for
oral iron drugs. Earlier, oral therapies were considered the gold
standard for the treatment of iron deficiency.

Key Vendors

  • AMAG Pharmaceuticals
  • AstraZeneca
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Pharmacosmos

Key Topics Covered

01. Executive Summary

02. Scope of the Report

03. Research Methodology

04. Market Landscape

05. Market Sizing

06. Five Forces Analysis

07. Market Segmentation by Application

08. Market Segmentation by Product

09. Customer Landscape

10. Regional Landscape

11. Decision Framework

12. Drivers and Challenges

13. Market Trends

14. Vendor Landscape

15. Vendor Analysis

16. Appendix

For more information about this report visit

View Comments and Join the Discussion!